Cancidas Related Clinical Trials
Pharmacokinetics of Caspofungin (Cancidas �) Given Intravenously as Therapy to Patients With an Invasive Fungal Infection in the Intensive Care Unit - a Search for Co-variates [Completed]
Caspofungin Maximum Tolerated Dose in Patients With Invasive Aspergillosis [Completed]
Open, Pharmacokinetic Study of Caspofungin Acetate in Immunocompromised Young Children With Febrile Neutropenia (0991-042) [Completed]
Pharmacokinetic, Safety and Efficacy of Intermittent Application of Caspofungin for Antifungal Prophylaxis [Completed]
Pilot Feasibility Study With Patients Who Are at High Risk For Developing Invasive Candidiasis in a Critical Care Setting (MK-0991-067) [Terminated]
Pharmacokinetics of Caspofungin in Burn Patients [Completed]
Pharmacokinetics and Pharmacodynamics of Caspofungin (Cancidas ®) and Drug Tolerance of Fungi to Patients With an Invasive Fungal Infection in the Intensive Care Unit [Enrolling by invitation]
Pharmacokinetics of Caspofungin After One Dose in Patients With Liver Failure [Recruiting]
Efficacy and Safety of Caspofungin for Invasive Pulmonary Aspergillosis Underlying Chronic Obstructive Pulmonary Disease [Recruiting]
Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant [Recruiting]
Effect of Weight and/or Obesity on Caspofungin Drug Concentrations [Completed]
Optimal Dosage of Caspofungin in Critically Ill Patients [Recruiting]
Acetato de Caspofungin (Cancidas®) in the Treatment of Fungal Infection [Completed]
A Study of Caspofungin Acetate (MK0991) for the Treatment of Esophageal Candidiasis or Invasive Candidiasis in Chinese Adults (MK-0991-066) [Completed]
Caspofungin Study for Fungal Infections in Adults in Critical Care Settings [Terminated]
A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074) [Completed]
A Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation [Completed]
Caspofungin as Prophylaxis in High Risk Liver Transplantation Recipients [Recruiting]
MK0991 Versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients (0991-044) [Completed]
A 28 - 90 Days Study to Evaluate the Safety, Tolerability, and Efficacy of Caspofungin Injection as Empirical Therapy in Indian Adults With Persistent Fever and Neutropenia (0991-053)(COMPLETED) [Completed]
Open, Pharmacokinetic Study of Caspofungin in Neonates and Infants (0991-058) [Completed]
Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU) [Completed]
An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Deep Tissue Infection Due To Candida [Terminated]
A Clinical Study of MK0991 (Caspofungin) in Japanese Patients With Deep-seated Candida or Aspergillus Infections (0991-062)(COMPLETED) [Completed]
An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Serious Fungal Infection Due To Candida In Patients With A Dysfunctional Immune System [Terminated]
Caspofungin Based Combined Anti-fungal Therapy for Proven or Probable Invasive Fungal Infection [Recruiting]
Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems [Terminated]
Comparison of Candida Eradication and Serum Cidal Activity of Echinocandins [Completed]
Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064) [Recruiting]
Caspofungin for the Treatment of Non-blood Candida Infections (0991-045) [Completed]
Prophylaxis With Caspofungin in High-Risk Liver Transplantation [Recruiting]
Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections [Completed]
Caspofungin or Micafungin as Empiric Antifungal Therapy for Persistent Fever and Neutropenia [Completed]
COMBISTRAT: AmBisome® in Combination With Caspofungin for the Treatment of Invasive Aspergillosis [Completed]
Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal Candidiasis [Completed]
Prophylaxis of Fungal Invasive Infections in Leukemia [Completed]
Evaluate the Safety and Efficacy of Caspofungin Acetate as Empirical Therapy in Chinese Adults With Persistent Fever and Neutropenia (0991-055) [Completed]
Study of Micafungin in Patients With Invasive Candidiasis or Candidemia [Completed]
Documented Candida or Aspergillus Infections in Pediatric Patients (0991-043) [Completed]
Caspofungin to Prevent Candidiasis in Adults in Hospital Intensive Care Units [Completed]
Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment [Completed]
Caspofungin Acetate in Treating Children With Fever and Neutropenia [Completed]
Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant [Completed]
Impact of a Loading Dose of Caspofungin in Invasive Candidiasis in ICU Patients [Not yet recruiting]
Empirical Versus Preemptive Antifungal Therapy [Recruiting]
MK0991 in Combination With Standard Antifungal Agent(s) for the Treatment of Salvage Invasive Aspergillosis (0991-037) [Completed]
A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults (0991-801)(COMPLETED) [Completed]
Liver Transplant European Study Into the Prevention of Fungal Infection [Completed]
A Laboratory-based Surveillance Study of Candida Bloodstream Infections (MK-0991-093) [Completed]
PEACE: Pediatric Antifungal Comparative Effectiveness [Recruiting]
Risk Of Severe Hepatic Injury In Patients With Invasive Candidiasis Treated With Echinocandins [Terminated]
Antifungal Use in Oncohematological Neutropenic Patients [Completed]
Antimicrobial PK in Infants With Suspected or Confirmed Infection [Completed]
Validation of an Index of Neutropenia (D-index) in Febrile Neutropenic Cancer Patients [Terminated]
Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents [Active, not recruiting]
A Study of the Side Effects of L-743,872 in Men With Candidal Esophagitis [Completed]
Safety and Effectiveness of Giving L-743,872 to Patients With Thrush That Has Not Been Cured With Fluconazole [Terminated]
Comparison of Fluconazole Versus Voriconazole to Treat Fungal Infections in Individuals Receiving Blood and Marrow Transplants [Completed]
Limited Access Protocol of Posaconazole in Invasive Fungal Infections Study PO2095 [Terminated]
|
